No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
465 |
4. Check minimum number of eventsNone |
465 |
5. Include endpointsNone |
465 |
6. Filter based on genotype QC (FinnGen only) |
424 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- G43
- Name in latin
- Hemicrania sine aura
Similar endpoints
↥List of similar endpoints to
Migraine without aura, drug-induced
based on the number of shared cases.
Similar with more cases:
- Migraine without aura
- Migraine
- Episodal and paroxysmal disorders
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 424 | 340 | 84 |
| Unadjusted period prevalence (%) | 0.10 | 0.12 | 0.04 |
| Median age at first event (years) | 31.23 | 33.01 | 24.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 434
- Matched controls
- 4340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
+∞
307.7
434
207
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
9.7
129.1
254
551
N02CC03
ATC
zolmitriptan; nasal, oral
10.1
95.8
130
177
N02CX04, ,
ATC
19.9
77.1
62
36
N02CC04
ATC
rizatriptan; oral
8.0
73.7
120
199
G43.9
ICD-10 Finland
Migraine, unspecified
7.3
72.1
130
240
N02CC06
ATC
eletriptan; oral
8.7
54.8
76
103
N05AB04
ATC
prochlorperazine; systemic, rectal
15.2
43.0
39
28
C07AA05
ATC
propranolol; systemic
3.9
41.6
186
698
N02CC02
ATC
naratriptan; oral
10.4
40.5
47
50
N02CC05
ATC
almotriptan; oral
6.0
35.8
70
135
M01AG02
ATC
tolfenamic acid; oral, rectal
3.7
33.9
148
535
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
13.1
33.6
33
27
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.4
31.5
94
259
N03AX11
ATC
topiramate; oral
7.2
31.3
49
75
G43.3
ICD-10 Finland
Complicated migraine
7.9
30.7
44
61
N06AA09
ATC
amitriptyline; systemic
4.5
29.2
81
210
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.3
29.2
86
234
R51
ICD-10 Finland
Headache
4.8
27.5
69
165
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
26.1
156
669
G43
ICD-10 Finland
Migraine
4.2
25.6
76
207
N02CC07
ATC
frovatriptan; oral
4.6
25.4
66
162
N03AG01
ATC
valproic acid; systemic, rectal
4.5
24.5
67
171
M01AE02
ATC
naproxen; oral, rectal
3.0
23.4
322
2109
C07AB02
ATC
metoprolol; systemic
3.3
22.1
101
366
3007
Kela drug reimbursment
Erenumab and fremanezumab
8.5
21.1
28
35
M01AE03
ATC
ketoprofen; systemic, rectal
2.6
20.8
192
1010
N89
ICPC
Migraine
4.6
19.6
50
120
G44.2
ICD-10 Finland
Tension-type headache
2.9
19.1
113
472
R51.80
ICD-10 Finland
Headache
2.8
19.0
126
558
G43.8
ICD-10 Finland
Other migraine
7.2
18.9
29
43
N05BA01
ATC
diazepam; systemic, rectal
3.0
16.8
84
318
M03BX02
ATC
tizanidine; oral
2.5
15.3
329
2409
C09CA06
ATC
candesartan; oral
2.4
14.2
135
698
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
13.0
203
1272
R518, ,
ICD-10 Finland
51.6
12.9
15
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
12.6
222
1451
N02CD01
ATC
erenumab; parenteral
12.9
12.2
21
17
C07AB07
ATC
bisoprolol; oral
2.1
11.9
188
1173
N03AX12
ATC
[U] gabapentin; oral
2.4
11.8
92
432
C08DA01
ATC
verapamil; systemic
4.2
11.1
30
75
N02AX02
ATC
tramadol; systemic, rectal
2.0
10.9
192
1237
A02BA02
ATC
ranitidine; systemic
2.4
10.8
88
420
UJF32
NOMESCO Finland
Coloscopy
2.2
10.5
109
576
A02BC01
ATC
omeprazole; systemic
2.1
10.2
130
742
A02BC02
ATC
pantoprazole; systemic
2.0
10.2
304
2326
N02CD02
ATC
galcanezumab; parenteral
20.6
9.9
14
7
A02BC03
ATC
lansoprazole; oral
2.0
9.7
130
754
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
9.5
133
782
N06AB04
ATC
citalopram; systemic
2.1
9.2
107
587
H02AB06
ATC
prednisolone; systemic
1.9
9.1
209
1445
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
8.5
123
728
R42
ICD-10 Finland
Dizziness and giddiness
2.0
8.2
101
565
N06AX11
ATC
mirtazapine; oral
1.8
7.9
167
1113
3460A
ICD-9 Finland
Migraine, Classical migraine
45.8
7.7
9
*
N03AX16
ATC
[U] pregabalin
1.9
7.6
107
625
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.6
7.5
25
73
N02CD03
ATC
fremanezumab; systemic
6.7
7.5
18
28
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
7.5
139
889
L04AA13
ATC
[U] leflunomide
4.5
7.0
17
39
A02BC05
ATC
esomeprazole; systemic
1.7
7.0
180
1261
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
6.9
46
200
J01FA10
ATC
azithromycin; systemic
1.7
6.8
289
2312
A02BX02
ATC
sucralfate; oral
4.0
6.8
19
49
N02CA01
ATC
dihydroergotamine; nasal, systemic
22.9
6.7
9
*
M01AH02
ATC
rofecoxib; oral
2.3
6.6
50
230
A03DA02
ATC
pitofenone and analgesics; systemic
7.0
6.6
15
22
N06AX21
ATC
duloxetine; oral
2.1
6.5
70
370
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.4
116
731
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
6.3
146
989
M54.5
ICD-10 Finland
Low back pain
1.7
6.1
180
1295
G01AF04
ATC
miconazole; vaginal
2.7
6.1
32
123
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.2
6.0
52
253
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
162
932
2.18
12.97
5.2
3.3
1.02
1.02
kg/l
1.19
110
599
210
1478
1.82
8.44
5.6
4.3
37.35
36.93
g/l
0.68
197
1404
272
2119
1.76
7.30
4.9
3.4
0.00
0.02
estimate
1.08
57
387
170
1164
1.76
7.20
4.0
2.4
54.95
63.16
u/l
1.05
161
1096
340
2842
1.91
7.09
6.3
4.1
9.26
9.66
mm/h
0.33
329
2689
269
2105
1.73
6.95
4.9
3.4
0.00
4.00
estimate
0.50
58
406
162
1105
1.74
6.89
5.5
3.4
0.02
0.00
estimate
0.40
57
396
267
2090
1.72
6.84
4.8
3.3
0.00
0.00
estimate
-0.00
58
406
58
284
2.20
6.60
2.6
2.4
72.29
72.82
ml/min/173m2
0.04
34
115
204
1499
1.68
6.51
6.1
6.1
1.20
1.22
mmol/l
2.56
198
1390
264
2084
1.68
6.33
5.8
4.5
6.24
6.36
mmol/l
0.51
257
1935
174
1239
1.67
6.17
2.4
3.0
2.34
2.36
mmol/l
0.90
159
1153
50
240
2.22
5.97
1.8
1.5
—
—
—
0
0
59
306
2.07
5.79
5.0
9.9
1.44
1.04
mmol/l
0.30
45
257
52
259
2.14
5.67
5.3
10.7
126.19
120.66
g/l
1.17
52
254
67
370
1.96
5.53
6.2
5.1
—
—
—
0
0
134
914
1.67
5.48
2.6
2.0
2.62
2.85
mg/l
0.70
125
784
210
1604
1.60
5.43
4.7
3.1
0.04
0.01
estimate
0.27
49
340
263
2120
1.61
5.41
3.7
3.1
81.30
84.06
ug/l
0.14
257
2010
332
2838
1.72
5.41
10.6
7.5
73.08
76.82
u/l
1.20
325
2706
53
278
2.03
5.05
1.7
1.4
—
—
—
0
0
64
359
1.92
5.04
1.9
1.8
—
—
—
0
0
77
459
1.82
5.02
2.5
2.0
29.33
29.20
s
0.07
77
448
22
81
2.81
4.58
2.8
3.5
—
768.57
—
0
7
48
252
2.02
4.57
3.4
2.3
0.18
0.21
e6/l
0.15
43
244
358
3174
1.73
4.53
5.8
4.7
14.62
14.49
pmol/l
0.57
344
2998
67
395
1.82
4.52
5.1
6.7
104.25
104.32
mmol/l
0.04
67
395
267
2211
1.54
4.49
12.0
9.5
4.03
3.93
e9/l
0.28
249
1942
146
1063
1.56
4.42
2.3
2.0
106.09
170.23
u/l
1.86
141
1018
117
813
1.60
4.31
1.5
1.3
11.89
11.97
u/ml
0.00
61
330
219
1763
1.49
4.04
2.7
2.5
75.80
75.95
nmol/l
0.03
213
1638
165
1261
1.50
3.90
4.5
3.1
13.83
79.06
ng/l
0.62
98
719
123
883
1.55
3.90
1.5
1.3
44.54
30.35
iu/ml
0.43
44
271
96
651
1.61
3.88
2.1
2.3
2.42
2.44
mmol/l
0.58
81
591
290
2487
1.50
3.81
5.1
4.1
750.43
535.70
e6/l
—
7
30
64
396
1.72
3.67
1.8
2.0
—
—
—
0
0
234
1934
1.46
3.63
7.1
5.8
9.88
10.16
umol/l
0.26
226
1849
73
472
1.66
3.55
2.5
2.2
24.60
23.62
%
0.21
68
440
31
153
2.11
3.50
4.3
12.5
17.47
16.11
%
2.16
31
147
208
1693
1.44
3.44
7.1
6.6
1.21
1.22
mmol/l
1.63
184
1462
96
674
1.54
3.32
1.8
1.6
136470991.01
51759234.51
pmol/l
0.39
85
597
60
376
1.69
3.29
1.9
1.7
—
—
—
0
0
142
1086
1.46
3.23
1.5
1.3
1.07
2.19
u/ml
0.87
61
310
370
3389
1.62
3.20
23.1
16.1
333.74
332.45
g/l
2.14
370
3379
19
79
2.47
3.18
2.3
2.0
—
—
—
0
0
109
794
1.50
3.16
3.7
3.1
425.47
782.34
ng/l
1.75
98
655
51
309
1.74
3.15
3.4
2.7
—
—
—
0
0
26
126
2.13
3.09
1.1
1.2
—
—
—
0
0
123
923
1.46
3.07
2.5
1.7
0.92
0.92
mg/l
0.01
99
701
26
127
2.11
3.03
1.2
1.1
—
—
—
0
0
137
1055
1.44
2.97
1.7
1.7
—
—
—
0
0
183
1485
1.40
2.95
2.1
2.0
99.19
99.20
pmol/l
0.00
98
759
72
489
1.57
2.87
2.1
2.0
—
—
—
0
0
54
344
1.65
2.79
1.4
1.4
19.68
27.04
iu/l
1.26
47
290
127
984
1.41
2.62
1.5
1.6
—
—
—
0
0
74
519
1.51
2.55
2.0
1.9
—
—
—
0
0
11
37
3.02
2.50
1.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
59
2.42
2.31
7.7
3.3
0.33
0.38
iu/ml
—
9
34
121
950
1.38
2.28
3.7
2.7
0.20
0.37
e6/l
1.39
100
671
56
380
1.54
2.25
2.6
2.6
29.89
37.40
u/l
0.82
45
318
405
3858
1.74
2.24
19.7
12.4
17.83
20.54
mg/l
1.29
341
3101
386
3638
1.55
2.19
4.7
4.4
5.69
5.73
mmol/l
0.28
374
3427
170
1419
1.33
2.13
4.2
3.1
29.62
29.10
u/l
0.06
162
1351
85
636
1.42
2.11
3.7
3.3
239.80
308.54
ng/l
0.11
51
401
5
10
5.04
2.07
4.8
3.4
7.82
10.85
kpa
—
5
10
5
10
5.04
2.07
4.8
3.4
5.58
4.88
kpa
—
5
10
38
240
1.64
2.07
1.1
1.0
—
—
—
0
0
418
4030
2.01
2.06
22.6
15.2
69.33
69.58
umol/l
0.11
418
3989
10
38
2.67
2.01
1.1
1.2
—
—
—
0
0
27
156
1.78
2.01
1.7
1.6
1.79
6.58
u/ml
—
7
36
33
203
1.68
1.99
1.8
1.4
—
—
—
0
0
14
64
2.23
1.96
1.6
1.4
—
—
—
0
0
10
39
2.60
1.95
1.9
1.7
—
—
—
0
0
63
454
1.45
1.92
2.9
2.2
7.18
7.33
umol/l
0.03
57
391
76
571
1.40
1.85
3.3
2.6
0.58
0.94
e6/l
0.86
49
272
62
453
1.43
1.76
1.7
1.6
1356.55
1179.62
nmol/l
0.97
51
345
383
3638
1.45
1.72
6.7
5.6
1.70
1.78
mu/l
1.05
371
3462
318
2940
1.31
1.67
3.4
3.7
—
—
—
0
0
10
40
2.53
1.67
1.1
1.2
—
—
—
0
0
10
40
2.53
1.67
1.1
1.2
—
—
—
0
0
7
25
2.83
1.65
1.6
1.0
1344.57
1801.04
miu/ml
—
7
25
5
14
3.60
1.62
1.8
2.2
134.02
97.84
ng/l
—
5
14
30
191
1.61
1.62
5.8
6.8
25.43
25.11
mmol/l
0.16
30
191
10
43
2.36
1.59
1.1
1.2
—
—
—
0
0
7
26
2.72
1.58
1.4
1.5
—
—
—
0
0
6
20
3.03
1.58
1.7
1.2
114.17
118.00
%
—
6
15
27
169
1.64
1.56
1.6
1.7
—
—
—
0
0
21
123
1.74
1.53
3.0
8.7
2.22
1.58
%
1.09
21
116
115
950
1.29
1.49
1.7
1.6
18.57
21.04
nmol/l
1.37
105
828
9
38
2.40
1.46
1.1
1.2
—
—
—
0
0
11
52
2.14
1.45
4.5
1.6
4.90
5.04
kpa
0.29
11
52
5
16
3.15
1.44
4.4
1.9
—
—
—
0
0
10
46
2.20
1.41
1.2
1.0
—
—
—
0
0
107
883
1.28
1.39
2.2
2.5
302.26
316.48
umol/l
0.84
97
802
31
208
1.53
1.37
1.3
1.5
—
—
—
0
0
204
1817
1.23
1.36
2.9
2.7
—
—
estimate
—
0
0
16
90
1.81
1.35
1.7
1.7
—
—
—
0
0
19
114
1.70
1.30
1.5
1.3
—
—
—
0
0
10
48
2.11
1.28
1.1
1.3
—
—
—
0
0
67
525
1.33
1.28
3.0
2.6
3.59
3.51
e6/l
0.02
37
225
14
77
1.85
1.27
1.3
1.2
1.00
2.35
u/ml
—
7
23
16
92
1.77
1.26
1.6
1.3
—
—
—
0
0
6
25
2.42
1.24
1.0
1.1
—
—
—
0
0
39
281
1.43
1.24
2.4
3.1
1.83
1.87
mmol/l
0.02
34
248
35
247
1.45
1.23
1.2
1.4
—
—
—
0
0
20
124
1.64
1.23
1.4
1.3
—
54.41
—
0
14
17
101
1.71
1.21
1.4
1.2
—
—
—
0
0
15
86
1.77
1.20
1.4
1.5
—
—
—
0
0
19
117
1.65
1.20
1.7
1.4
353.23
329.54
ug/g
0.18
13
65
21
133
1.61
1.19
1.3
1.5
0.01
0.06
iu/ml
—
5
13
6
26
2.33
1.19
1.3
1.2
90.83
152.23
iu/ml
—
6
26
14
79
1.80
1.18
1.2
1.3
1.57
7.72
u/ml
—
7
29
18
111
1.65
1.14
1.3
1.3
—
—
—
0
0
14
81
1.75
1.10
1.9
1.5
—
—
—
0
0
51
394
1.33
1.09
1.3
1.3
122.43
155.79
u/ml
0.32
27
172
10
52
1.94
1.07
1.0
1.1
—
—
—
0
0
185
1663
1.20
1.05
1.9
1.9
1.45
1.38
mmol/l
0.45
164
1465
414
4042
1.53
1.05
14.9
10.7
26.38
25.95
u/l
0.23
409
3958
27
188
1.47
1.04
2.8
1.9
4.36
5.48
iu/ml
—
8
43
5
22
2.29
1.03
1.8
1.3
—
—
—
0
0
28
197
1.45
1.03
3.0
2.0
—
—
—
0
0
22
147
1.52
1.02
1.7
2.0
1.68
4.40
iu/l
—
8
60
9
47
1.93
1.02
2.4
1.4
—
—
—
0
0
10
53
1.91
1.02
1.4
1.8
—
—
—
0
0
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
0
32
0.00
0.95
0.0
1.3
—
9.28
—
0
32
138
1218
1.20
0.95
3.3
2.6
0.00
0.01
estimate
1.08
49
341
7
37
1.91
0.94
1.6
1.2
—
—
—
0
0
6
27
2.24
0.94
4.2
4.6
387.83
630.07
u/ml
—
6
27
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
17
111
1.55
0.89
1.4
1.3
—
1.04
—
0
7
8
44
1.83
0.86
1.4
1.1
—
—
—
0
0
364
3512
1.23
0.82
5.6
5.3
37.41
37.96
mmol/mol
0.83
352
3351
427
4218
1.76
0.79
28.5
19.8
40.85
40.57
%
0.91
427
4188
427
4219
1.75
0.79
28.4
19.6
136.20
135.54
g/l
0.52
427
4190
393
3827
1.28
0.79
4.8
4.5
1.47
1.52
mmol/l
1.97
384
3635
427
4216
1.79
0.79
28.1
19.5
90.47
90.47
fl
0.00
427
4188
0
26
0.00
0.78
0.0
1.8
—
14.74
—
0
14
10
59
1.71
0.76
1.9
1.6
—
—
—
0
0
9
55
1.65
0.74
1.8
1.5
—
—
—
0
0
20
142
1.43
0.73
1.4
1.2
—
—
—
0
0
11
68
1.63
0.72
1.9
1.5
—
—
—
0
0
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
39
483
0.79
0.70
2.0
1.8
3.79
3.49
mmol/l
0.52
23
346
21
153
1.39
0.68
1.4
1.3
—
20.37
—
0
9
396
3873
1.26
0.65
5.5
5.1
2.86
2.87
mmol/l
0.04
388
3678
22
164
1.36
0.63
1.3
1.4
—
—
—
0
0
8
49
1.64
0.62
2.3
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
10
64
1.58
0.59
5.5
2.4
8.17
6.12
pmol/l
—
10
64
12
82
1.48
0.55
5.1
2.4
—
—
—
0
0
9
61
1.49
0.54
2.3
1.3
—
—
—
0
0
392
3842
1.21
0.53
5.0
4.6
4.80
4.83
mmol/l
0.29
384
3655
6
39
1.55
0.53
1.3
2.1
—
—
—
0
0
9
63
1.44
0.52
1.3
1.5
8.01
7.13
mmol/l
—
9
54
9
64
1.41
0.51
1.2
1.2
—
253.33
—
0
6
7
47
1.50
0.47
5.7
3.4
14.47
45.11
u/ml
—
7
47
22
173
1.29
0.47
1.5
1.8
—
—
—
0
0
7
51
1.38
0.44
1.0
1.2
88.86
95.09
%
—
7
46
7
51
1.38
0.44
1.6
1.2
18.95
17.19
u/l
—
7
42
26
213
1.23
0.42
1.0
1.2
0.86
0.91
g/l
0.62
26
213
298
2886
1.10
0.41
3.6
3.2
44.58
38.51
u/l
0.61
288
2771
22
270
0.80
0.40
1.5
1.5
—
—
—
0
0
5
34
1.48
0.40
1.0
1.2
116.40
109.00
pmol/l
—
5
34
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
10
71
1.42
0.39
1.1
1.1
—
—
—
0
0
11
80
1.38
0.38
1.1
1.3
—
—
—
0
0
18
224
0.80
0.37
1.8
1.5
0.90
0.99
ratio
0.50
11
145
18
224
0.80
0.37
1.8
1.5
1.18
1.16
ratio
0.03
11
145
18
224
0.80
0.37
1.8
1.5
1.20
1.22
ratio
0.03
11
145
9
71
1.27
0.36
1.4
1.1
—
—
—
0
0
373
3663
1.13
0.36
17.2
11.5
88.96
89.15
ml/min/173m2
0.07
356
3347
125
1169
1.10
0.36
3.4
3.2
8.62
7.77
mmol/l
1.10
118
1008
6
41
1.47
0.36
1.2
1.4
—
—
—
0
0
16
126
1.28
0.35
1.3
1.1
4.00
4.74
—
5
21
18
222
0.80
0.35
1.7
1.5
—
—
—
0
0
25
209
1.21
0.35
1.0
1.2
1.45
1.56
g/l
1.49
25
209
18
146
1.24
0.32
1.4
1.3
—
2.97
—
0
16
15
185
0.80
0.30
2.2
1.6
—
—
—
0
0
19
228
0.83
0.30
2.3
2.3
0.66
0.70
ug/l
—
10
99
369
3631
1.11
0.30
4.1
3.9
1.31
1.24
mmol/l
0.95
359
3423
8
108
0.74
0.29
1.1
1.5
—
—
—
0
0
5
71
0.70
0.26
10.2
2.1
1.40
0.92
nmol/l
—
5
59
21
245
0.85
0.25
4.8
3.6
116.78
74.81
ng/l
0.74
21
217
30
265
1.14
0.24
2.8
2.4
2543.02
5359.30
u/l
0.57
13
123
7
91
0.77
0.22
4.4
1.2
3.07
2.77
ug/l
—
7
84
18
210
0.85
0.22
1.2
1.6
0.15
0.29
mg/l
—
7
88
57
615
0.92
0.22
1.8
2.0
3.58
3.41
ratio
0.40
37
475
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
74.80
—
0
10
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
6
50
1.20
0.20
1.7
1.2
0.15
0.17
nmol/l
—
6
35
27
301
0.89
0.19
2.8
3.9
3.43
7.72
ug/l
1.40
20
241
10
122
0.82
0.19
1.2
1.1
3.55
2.44
u/ml
—
5
68
8
70
1.15
0.16
4.4
6.9
383.38
365.02
umol/l
—
8
65
6
78
0.77
0.15
1.2
1.3
—
—
—
0
0
13
114
1.14
0.12
5.1
2.9
12.10
10.74
mg/l
0.32
13
108
32
298
1.08
0.12
2.7
3.7
24.41
22.83
%
0.25
12
93
24
221
1.09
0.11
1.4
1.3
331.10
248.29
miu/ml
0.42
12
109
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
7
66
1.06
0.08
1.0
2.0
—
—
—
0
0
6
70
0.86
0.07
1.2
1.3
—
—
—
0
0
6
70
0.86
0.07
1.2
1.3
—
—
—
0
0
60
580
1.04
0.07
1.7
1.8
1.27
1.36
%
0.55
52
522
20
186
1.08
0.07
3.1
3.4
5.03
5.19
kpa
0.49
20
180
20
187
1.07
0.06
4.3
2.6
39.33
39.84
u/l
0.05
20
170
12
110
1.09
0.05
1.4
1.3
3.66
3.70
mmol/l
0.06
12
103
13
120
1.09
0.05
1.4
1.3
762.92
450.33
mg/l
0.78
13
115
13
140
0.93
0.04
1.5
1.5
65.59
55.07
ug/l
0.45
13
140
80
785
1.02
0.04
2.3
2.2
—
—
—
0
0
18
170
1.06
0.04
1.1
1.3
—
—
—
0
0
90
914
0.98
0.03
2.0
2.1
—
—
—
0
0
10
106
0.94
0.01
1.3
1.2
—
—
—
0
0
14
139
1.01
0.00
1.2
1.4
66.86
177.96
pmol/l
0.76
14
134
16
159
1.01
0.00
1.6
1.8
—
—
—
0
0
73
725
1.01
0.00
2.2
2.1
—
—
—
0
0
102
1015
1.01
0.00
3.9
4.0
4.81
9.03
mg/mmol
0.89
64
592
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
8.43
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
45.40
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
0.13
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: G6_MIGRAINE_NO_AURA_ADVERSE – Migraine without aura, drug-induced
GWS hits: 1
This endpoint is excluded (not available in FinRegistry).